FDA.reportPublic FDA data

Amphetamine/methamphetamine group IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of the amphetamine and/or methamphetamine group(s) in a clinical specimen.
GUDID devices
12
Last updated
2020-10-05 06:30:15

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00811727016591Pointe Amphetamines 500 Level 1 Control (MAMP 375 ng/mL)HORIBA INSTRUMENTS INCORPORATED60-AM0214-52020-09-25
00811727016607Pointe Amphetamines 500 Level 2 Control (MAMP 625 ng/mL)HORIBA INSTRUMENTS INCORPORATED60-AM0216-52020-09-25
00811727016676Pointe Amphetamines 1000 Level 1 Control (MAMP 750 ng/mL)HORIBA INSTRUMENTS INCORPORATED60-AM0094-52020-09-25
00811727016683Pointe Amphetamines 1000 Level 2 Control (MAMP 1250 ng/mL)HORIBA INSTRUMENTS INCORPORATED60-AM0096-52020-09-25
B800414005Amphetamines Panel Level 1UTAK LABORATORIES, INC.414002020-04-15
B800414015Amphetamines Panel Level 2 UTAK LABORATORIES, INC.414012020-04-15
B07601670Ecstasy DAU Control, Level 1 ControlLIN-ZHI INTERNATIONAL, INC.01672016-07-05
B07601680Ecstasy DAU Control, Level 2 ControlLIN-ZHI INTERNATIONAL, INC.01682016-07-05
05055273207934MDMA CONTROL 1RANDOX LABORATORIES LIMITEDDA31252016-09-24
05055273207941MDMA CONTROL 2RANDOX LABORATORIES LIMITEDDA31262016-09-24
00858724003568ARK™ Methylphenidate Metabolite ControlARK DIAGNOSTICS INC5042-0003-002018-09-29
00884883006843DRI MDA ControlMicrogenics Corporation100244352018-09-27